Assay ID | Title | Year | Journal | Article |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
AID380852 | Cytotoxicity against human PaCa2 cells | 1999 | Journal of natural products, Aug, Volume: 62, Issue:8
| Tryptamine derived amides and acetogenins from the seeds of Rollinia mucosa. |
AID492254 | Antioxidant activity in mesecephalic neuron assessed as ROS production at 10 nM by dihydrorhodamine-123 incorporation assay relative to control | 2010 | Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
| Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons. |
AID380851 | Cytotoxicity against human PC-3 cells | 1999 | Journal of natural products, Aug, Volume: 62, Issue:8
| Tryptamine derived amides and acetogenins from the seeds of Rollinia mucosa. |
AID380847 | Cytotoxicity against human A549 cells | 1999 | Journal of natural products, Aug, Volume: 62, Issue:8
| Tryptamine derived amides and acetogenins from the seeds of Rollinia mucosa. |
AID380846 | Toxicity in Artemia salina | 1999 | Journal of natural products, Aug, Volume: 62, Issue:8
| Tryptamine derived amides and acetogenins from the seeds of Rollinia mucosa. |
AID492251 | Neuritogenic effect in rat DA neurons assessed as total neurite length per tyrosine hydrolase immunopositive neurons at 10 nM relative to control | 2010 | Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
| Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons. |
AID492249 | Neuroprotective activity against degeneration of rat DA neurons assessed as tyrosine hydrolase immunopositive neurons at 10 nM by immunofluorescence staining relative to control | 2010 | Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
| Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons. |
AID380850 | Cytotoxicity against human A298 cells | 1999 | Journal of natural products, Aug, Volume: 62, Issue:8
| Tryptamine derived amides and acetogenins from the seeds of Rollinia mucosa. |
AID492253 | Antioxidant activity assessed as ABTS radical scavenging activity | 2010 | Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
| Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons. |
AID380848 | Cytotoxicity against human MCF7 cells | 1999 | Journal of natural products, Aug, Volume: 62, Issue:8
| Tryptamine derived amides and acetogenins from the seeds of Rollinia mucosa. |
AID380849 | Cytotoxicity against human HT-29 cells | 1999 | Journal of natural products, Aug, Volume: 62, Issue:8
| Tryptamine derived amides and acetogenins from the seeds of Rollinia mucosa. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |